Skip to main content

Risk Register - Methodology

Purpose

The Risk Register is used to formally track and maintain all documented risk entries within Scheol Security Lab.

Its role is to centralise the output of the risk modeling process and provide a structured view of:

  • what has been identified as a meaningful risk
  • what asset or capability is concerned
  • what scenario the risk is based on
  • how the risk has been evaluated
  • what treatment decision has been made
  • what controls or follow-up actions are associated with it

The register therefore acts as a core traceability layer between risk reasoning, security decisions and later validation or review activities.


Documentation Logic

Each risk entry in the register represents an evaluated and reviewable risk situation, not a generic concern or isolated observation.

A valid risk entry should always be grounded in:

  • a documented asset or capability
  • a documented threat scenario
  • a documented evaluation logic
  • a documented treatment posture

This means the register is not intended to be a loose list of “security problems”, but a structured catalogue of risks that can be reviewed over time.


Register Structure

In Scheol, each identified risk is documented as an individual Markdown file using the R-00X.md naming convention.

This allows each risk to remain:

  • individually reviewable
  • versioned over time
  • easy to cross-reference
  • compatible with the broader documentation model of the lab

Expected Fields

Each risk entry should progressively include the following elements:

FieldDescription
Risk IDUnique identifier (e.g. R-001)
TitleShort and explicit risk title
Target Asset / CapabilityLink to the impacted asset, platform, information asset or business capability
Related ScenarioLink to the associated threat scenario (S-00X.md)
LikelihoodQualitative likelihood assessment
ImpactOverall impact rating derived from the selected criteria
Risk LevelResulting risk level based on the Risk Matrix
Treatment DecisionAccept, Mitigate, Transfer or Avoid
Treatment RationaleShort justification for the chosen treatment posture
Owner / Review RoleResponsible role for follow-up or review
Associated ControlsExisting or planned safeguards related to the risk
Residual ConcernsRemaining uncertainty, gaps or limitations
ReferencesRelevant documentation, framework references or linked pages
Last ReviewDate of most recent review
Next ReviewPlanned review date

This structure is intended to support both clarity and traceability.


How the Register Is Used

The Risk Register acts as the formal bridge between risk analysis and downstream documentation.

It is used to support:

  • prioritisation and treatment decisions
  • control mapping and implementation follow-up
  • review of residual exposure
  • evidence and traceability logic
  • future audit-oriented review activities

It is therefore one of the main places where the lab’s governance posture becomes visible.


Documentation Conventions

To maintain consistency across the lab:

  • each risk is documented as a separate Markdown file
  • each risk must reference at least one related threat scenario
  • each risk should remain linked to the relevant asset or capability
  • significant updates should trigger a version increment
  • minor wording or metadata changes should update last_updated

Expected front matter includes:

  • title
  • version
  • last_updated
  • owner
  • review_frequency

Relationship with Other Pages

The Risk Register should be read as part of the broader documentation chain:

This layered structure is intentional and supports both readability and methodological coherence.


Current Maturity

At the current stage, the Risk Register in Scheol Security Lab is considered partially established.

Established

  • overall register logic and file-based structure
  • baseline linkage between assets, scenarios and risk entries
  • naming convention and documentation expectations
  • initial population of core risk entries

In Progress

  • broader coverage across all implemented and planned components
  • consistency of treatment rationale and review metadata
  • stronger linkage between risk entries, controls and validation activities
  • improved completeness and documentary quality across entries

Planned / Next Phase

  • more complete population of the register across all major lab domains
  • stronger support for evidence traceability and audit-oriented review
  • improved linkage between treatment decisions and monitoring outcomes
  • better integration with future governance and control mapping activities

This page is therefore expected to evolve as the risk model, infrastructure coverage and documentation maturity continue to grow.